Literature DB >> 18822061

Nevi with site-related atypia: a review of melanocytic nevi with atypical histologic features based on anatomic site.

Gregory A Hosler1, Jean Margaret Moresi, Terry L Barrett.   

Abstract

A subset of melanocytic nevi share features with melanoma and nevi with architectural disorder but are biologically inert and to date do not appear to portend an increased risk for the development of malignancy. These benign nevi with certain atypical histologic features cluster among specific anatomic sites and are thus designated nevi with site-related atypia. We categorize these lesions into four main groups: acral, genital, special site and conjunctival, based on anatomy and relative prevalence of specific atypical histologic features. As the literature and our recognition of these lesions continue to grow, our understanding of their biology has not kept pace.

Entities:  

Mesh:

Year:  2008        PMID: 18822061     DOI: 10.1111/j.1600-0560.2008.01041.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

1.  Dermoscopic and clinical features of pigmented skin lesions of the genital area.

Authors:  Fatma Pelin Cengiz; Nazan Emiroglu; Rainer Hofmann Wellenhof
Journal:  An Bras Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.896

2.  Dermoscopic and confocal features of an axillary "special site" nevus.

Authors:  Riana Dutt; Harold S Rabinovitz; Rajendra Singh; Alon Scope
Journal:  Dermatol Pract Concept       Date:  2017-01-31

3.  Label-Free Imaging of Female Genital Tract Melanocytic Lesions With Pump-Probe Microscopy: A Promising Diagnostic Tool.

Authors:  Francisco E Robles; Sanghamitra Deb; Martin C Fischer; Warren S Warren; Maria Angelica Selim
Journal:  J Low Genit Tract Dis       Date:  2017-04       Impact factor: 1.925

4.  A juvenile case of conjunctival atypical nevus.

Authors:  Cristina Colarossi; Mario Milazzo; Milena Paglierani; Daniela Massi; Lorenzo Memeo; Vincenzo Canzonieri
Journal:  Diagn Pathol       Date:  2013-04-22       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.